Table 2.
RBC fatty acid compositiona at baseline and following supplementation
Fish oil group | Placebo group | |||||
---|---|---|---|---|---|---|
Week 0 Mean (s.d.) | Week 18 Mean (s.d.) | Absolute Change (95% CI) | Week 0 Mean ± s.d. | Week 18 Mean ± s.d. | Absolute Change (95% CI) | |
EPA | 0.46% (0.26) | 1.45% (0.75) | 1.00% (0.86–1.14) | 0.45% (0.23) | 0.41% (0.89) | −0.03% (−0.76 to 0.06) |
DHA | 2.53% (0.92) | 3.50% (1.12) | 1.02% (0.80–1.24) | 2.48% (0.89) | 2.44% (0.97) | 0.01% (−0.14 to 0.17) |
Expressed as percentage of total fatty acids.